Ovarian Reserve teaser

OVARIAN RESERVE (PREDICTING FERTILITY POTENTIAL IN WOMEN)

Download a PDF of this document

Revised 2023


A woman’s ability to get pregnant normally decreases as she gets older. In later life, women have fewer eggs, egg quality goes down, and eggs have more abnormalities in their chromosomes (genetic material). All these factors together mean that older women have lower pregnancy rates and higher miscarriage rates.

The ability to have a baby decreases in all women as they get older, but the exact age when a woman can no longer conceive varies from woman to woman. In some women, this happens at a younger age than would normally be expected. About one third of couples will have problems getting pregnant when the female partner is age 35 or older. There are several tests that can help show a woman’s fertility potential, also called ovarian reserve.

Blood tests: FSH, Estradiol, and AMH

One common way to test ovarian reserve is by measuring hormone blood levels. Follicle-stimulating hormone (FSH) and estradiol are checked at the beginning of the menstrual cycle. This is usually done on cycle day 3, but it can be drawn from day 1 to 5. These hormone levels can show important information about how the ovaries and pituitary gland are working together.

The pituitary gland makes FSH to make a follicle grow. A follicle is a small fluid filled cyst in the ovary that contains the egg. Usually, FSH levels are lowest in the beginning of the menstrual cycle and then go up, causing a follicle to grow and the egg to mature. As this happens, the follicle releases estradiol. In turn, these higher levels of estradiol tell the pituitary gland to make less FSH. If the egg and follicle start to grow too early because FSH is already rising, estradiol is produced faster. If development is too fast, the egg does not mature properly.

In general, women whose cycle day-3 levels of FSH and/or estradiol are high are less likely to have a baby after either ovulation induction or in vitro fertilization (IVF) compared with other women of the same age.

Anti-müllerian hormone (AMH) is a vital test for checking ovarian reserve. It’s made in the follicles, which houses the eggs, and its levels can be checked at any time during the menstrual cycle. Unlike FSH, which is done less often now, prioritizing tests in this order is crucial: AMH first, then counting egg homes (AFC), and if needed, checking FSH/ E2. Going deeper into it, AMH is an extra sensitive marker, giving important insights into ovarian reserve and fertility potential. This order of testing gives a complete evaluation, following the latest practices in fertility assessment. You should know that laboratory procedures and “normal” levels vary from lab to lab. It can be difficult to compare results from one laboratory to another.

Clomiphene Citrate Challenge Test (CCCT)

In the past, a test called Clomiphene Citrate Challenge Test (CCCT) was used to predict how ovaries would respond to IVF cycles. It involved taking clomiphene citrate early in the menstrual cycle, measuring FSH and estradiol levels before and after. High FSH levels suggested lower pregnancy rates with ovulation induction therapy and IVF. However, this test is rarely done now as other improved testing methods are preferred.

Antral follicle count

A transvaginal ultrasound may be done in the early part of the menstrual cycle to count the number of small (2mm- 10mm) follicles in the ovary. These are called antral follicles and are where eggs develop. The number of antral follicles can tell us how many eggs are available and about the woman’s response to fertility medicines. This test is more accurate when it is done by a health-care provider who is experienced in working with fertility evaluations.

What these tests tell us

These tests try to predict a woman’s response to fertility treatment and how likely she is to get pregnant compared to other women of the same age. Abnormal ovarian reserve test results suggest that fertility potential has declined but they do not tell who will or who will not conceive. It is also possible that younger women with normal test results may have difficulty conceiving. Results may vary from cycle to cycle; however, any one abnormal test generally shows that fertility potential has decreased.

The chance of getting pregnant is primarily related to the quality of the eggs. Women over the age of 35 with abnormal test results who have not had successful treatment have a lower chance of conceiving. These women may be candidates to use eggs or embryos from a donor. Even with a normal ovarian reserve test, older women may have difficulty conceiving.

No single test of ovarian reserve can definitively predict a woman’s ability to get pregnant. These tests are often used to develop a treatment plan, including the need for donor eggs or embryos.

Ovarian Reserve 2.png

 

 




 

Ovarian Reserve 7.pngOvarian Reserve 8.pngOvarian Reserve 9.pngOvarian Reserve 10.pngOvarian Reserve 11.pngOvarian Reserve 12.png

 

 

Ovarian Reserve 13.pngOvarian Reserve 14.png

Ovarian Reserve

Podcast Icon

SART Fertility Experts - Understanding Ovarian Reserve

What an alphabet soup of terms exists to describe ovarian reserve!  Listen to the Episode
Patient Ed Icon

What is Premature Ovarian Insufficiency (Previously Called Premature Ovarian Failure)?

When a woman’s ovaries stop working before age 40, she is said to have premature ovarian insufficiency (POI).  View the fact sheet
Patient Ed Icon

Mary Dolan's Story

I was diagnosed with diminished ovarian reserve/premature ovarian failure at 28 years old.
Read the story
Patient Ed Icon

Kristen Ritchie's Story

I spent seven years navigating infertility, which was tumultuous but also a period of tremendous personal growth in hindsight. Read the story
Infographic Icon

Ovarian Reserve Infographics

ASRM has prepared infographics to illustrate the subject of Ovarian Reserve better. View the Infographics

Fact Sheets/Booklets

View more fact sheets and booklets written by the ASRM Patient Education Committee.
Patient Factsheet teaser

Menopausal Transition (Perimenopause): What Is It?

The menopausal transition (perimenopause) is the period that links a woman’s reproductive (childbearing) years and menopause.
Patient Factsheet teaser

Osteoporosis

Osteoporosis and osteopenia are conditions of having low bone mass (density).
Patient Factsheet teaser

Stress and infertility

It is not clear how exactly stress impacts fertility.
Patient Factsheet teaser

Optimizing Natural Fertility

Before attempting pregnancy, a woman should make sure she is healthy enough for pregnancy by adopting a healthier lifestyle and taking prenatal vitamins. If she has a medical or genetic condition or risk of one, she should seek advice from a medical professional before conceiving (becoming pregnant)

Resources For You

The American Society for Reproductive Medicine (ASRM) is committed to providing patients with the highest quality information about reproductive care.

Find a Health Professional

Connect with reproductive medicine experts who will guide you through your unique journey. Our search tool allows personalized matches based on location, specialization, and expertise. Take control of your reproductive health with compassionate providers, innovative treatments, and unwavering support.
Search for an Expert
Healthcare professional eager to help a patient